Pharmacists' Readiness to Receive, Recommend and Administer COVID-19 Vaccines in an African Country: An Online Multiple-Practice Settings Survey in Nigeria.
COVID-19 vaccine
Pharmacists
hesitancy
recommend
vaccination
virus
Journal
Malawi medical journal : the journal of Medical Association of Malawi
ISSN: 1995-7270
Titre abrégé: Malawi Med J
Pays: Malawi
ID NLM: 9500170
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
entrez:
2
3
2022
pubmed:
3
3
2022
medline:
8
3
2022
Statut:
ppublish
Résumé
Without a cure, vaccination is the most reliable means of combating COVID-19 pandemic, since non-pharmacological measures could not prevent its spread, as evidenced in the emergence of a second wave. This study assessed the readiness of pharmacists to receive, recommend and administer COVID-19 vaccines to clients in Nigeria. This was a cross-sectional study in which responses were collected from pharmacists in Nigeria through Google Form link. A 21-item questionnaire was developed and validated for the study. The link was shared on the WhatsApp groups of eligible respondents. The response was downloaded into Microsoft Excel (2019) and cleared of errors. This was uploaded into KwikTables (Beta Version 2021) for data analysis. Descriptive statistics such as frequencies and percentages were used to describe the data. Chi-squared test was used to determine the relationship between all the responses and the practice areas of the pharmacists. A total of 509 pharmacists responded to the study, but 507 indicated their areas of practice. The highest response of 247(48.7%) was obtained from hospital pharmacists, then community pharmacists; 157(31.0%). Hospital and community pharmacists accounted for 96 and 66 of the 191(37.7%) pharmacists that would probably accept the vaccine (p=0.126). The Pfizer-bioNTech vaccine was the preferred brand for 275(54.2%) respondents. Healthcare Professionals>Elderly>General Populace>Children was the order of roll-out recommended by 317(62.5%). Adverse-effect-following-immunization was the concern of 330(65.1%) pharmacists. Age was a factor in their likelihood of recommending the COVID-19 vaccine to clients (p=0.001). This study established that most pharmacists are willing to accept to be vaccinated against COVID-19, recommend and administer it to other citizens. They were impressed by the effectiveness and cost of some of the vaccines, but were concerned about their possible adverse effects. The pharmacists would want the authorities to consider strategies that will make the vaccines accessible to all citizens.
Sections du résumé
Background
Without a cure, vaccination is the most reliable means of combating COVID-19 pandemic, since non-pharmacological measures could not prevent its spread, as evidenced in the emergence of a second wave. This study assessed the readiness of pharmacists to receive, recommend and administer COVID-19 vaccines to clients in Nigeria.
Methods
This was a cross-sectional study in which responses were collected from pharmacists in Nigeria through Google Form link. A 21-item questionnaire was developed and validated for the study. The link was shared on the WhatsApp groups of eligible respondents. The response was downloaded into Microsoft Excel (2019) and cleared of errors. This was uploaded into KwikTables (Beta Version 2021) for data analysis. Descriptive statistics such as frequencies and percentages were used to describe the data. Chi-squared test was used to determine the relationship between all the responses and the practice areas of the pharmacists.
Results
A total of 509 pharmacists responded to the study, but 507 indicated their areas of practice. The highest response of 247(48.7%) was obtained from hospital pharmacists, then community pharmacists; 157(31.0%). Hospital and community pharmacists accounted for 96 and 66 of the 191(37.7%) pharmacists that would probably accept the vaccine (p=0.126). The Pfizer-bioNTech vaccine was the preferred brand for 275(54.2%) respondents. Healthcare Professionals>Elderly>General Populace>Children was the order of roll-out recommended by 317(62.5%). Adverse-effect-following-immunization was the concern of 330(65.1%) pharmacists. Age was a factor in their likelihood of recommending the COVID-19 vaccine to clients (p=0.001).
Conclusion
This study established that most pharmacists are willing to accept to be vaccinated against COVID-19, recommend and administer it to other citizens. They were impressed by the effectiveness and cost of some of the vaccines, but were concerned about their possible adverse effects. The pharmacists would want the authorities to consider strategies that will make the vaccines accessible to all citizens.
Identifiants
pubmed: 35233279
doi: 10.4314/mmj.v33i3.9
pmc: PMC8843180
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-220Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The College of Medicine and the Medical Association of Malawi.
Références
Hum Vaccin Immunother. 2016 Mar 3;12(3):623-31
pubmed: 26810485
Can Pharm J (Ott). 2018 Jan 02;151(1):4-5
pubmed: 29317929
Can Pharm J (Ott). 2019 Oct 09;152(6):391-394
pubmed: 31762851
Vaccine. 2018 Jun 18;36(26):3861-3867
pubmed: 29605516
Niger Postgrad Med J. 2020 Oct-Dec;27(4):261-267
pubmed: 33154276
Res Social Adm Pharm. 2021 Jan;17(1):1964-1966
pubmed: 32317154
BMJ Open. 2016 Sep 20;6(9):e011948
pubmed: 27650763
J Community Health. 2021 Aug;46(4):752-757
pubmed: 33156454
Int J Clin Pharm. 2015 Apr;37(2):292-5
pubmed: 25687902
JAMA. 2021 Jan 26;325(4):327-328
pubmed: 33404589
Pharm Pract (Granada). 2020 Jul-Sep;18(3):2142
pubmed: 32922575
Pharmacy (Basel). 2020 Oct 26;8(4):
pubmed: 33114654